Updated phase 3 titration pathway The phase 3 schedule uses the following escalation: Weeks 1-4: 2mg weekly Weeks 5-8: 4mg weekly Weeks 9-12: 8mg weekly Week 13+: Maintenance dose (4mg, 9mg, or 12mg depending on assignment) The introduction of a 9mg dose option is interesting
Physical activity becomes easier as weight decreases and fitness improves
Dulaglutide similarly reduced plaque area in Apoe/ atherosclerotic mice, with early-stage diabetes intervention resulting in significantly lower infiltration of macrophages into aortic root lesions, compared to late-stage treatment [32]
This double agonist approach seems to cause people who use Zepbound and Mounjaro injections to lose more weight than those who use single-agonist medication like Ozempic and Wegovy
The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health
GLP-1 Orders for Patients with Diabetes Q1 2026 Quarterly rates per 100,000 of patients with documentation of type 2 diabetes and receiving clinical care receiving a prescription, dispense, or reporting starting a GLP-1 medication